By rray, 31 October, 2023 Patient Type Header (Long) Infants and Children 0-19 mo Does this Patient Type contain sub types? No Patient Type Details Nirsevimab alip Beyfortus is generally recommended for all infants If nirsevimab is administered 3 Precautions and Contradictions Report adverse events to the Vaccine Adverse Event Reporting System https vaers hhs gov index html or 1 800 822 7967